Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cutaneous Radiation Injury Drug Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral Drug
1.4.3 Topical Drug
1.5 Market by Application
1.5.1 Global Cutaneous Radiation Injury Drug Market Share by Application (2019-2025)
1.5.2 Hospital Pharmacies
1.5.3 Online Pharnacies
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cutaneous Radiation Injury Drug Market Size
2.2 Cutaneous Radiation Injury Drug Growth Trends by Regions
2.2.1 Cutaneous Radiation Injury Drug Market Size by Regions (2019-2025)
2.2.2 Cutaneous Radiation Injury Drug Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Cutaneous Radiation Injury Drug Market Size by by Players
3.1.1 Global Cutaneous Radiation Injury Drug Revenue by by Players (2014-2019)
3.1.2 Global Cutaneous Radiation Injury Drug Revenue Market Share by by Players (2014-2019)
3.1.3 Global Cutaneous Radiation Injury Drug Market Concentration Ratio (CR5 and HHI)
3.2 Cutaneous Radiation Injury Drug Key Players Head office and Area Served
3.3 Key Players Cutaneous Radiation Injury Drug Product/Solution/Service
3.4 Date of Enter into Cutaneous Radiation Injury Drug Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cutaneous Radiation Injury Drug Market Size by Type (2014-2019)
4.2 Global Cutaneous Radiation Injury Drug Market Size by Application (2014-2019)
5 North America
5.1 North America Cutaneous Radiation Injury Drug Market Size (2014-2019)
5.2 Cutaneous Radiation Injury Drug Key Players in North America
5.3 North America Cutaneous Radiation Injury Drug Market Size by Type
5.4 North America Cutaneous Radiation Injury Drug Market Size by Application
6 Europe
6.1 Europe Cutaneous Radiation Injury Drug Market Size (2014-2019)
6.2 Cutaneous Radiation Injury Drug Key Players in Europe
6.3 Europe Cutaneous Radiation Injury Drug Market Size by Type
6.4 Europe Cutaneous Radiation Injury Drug Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific Cutaneous Radiation Injury Drug Market Size (2014-2019)
7.2 Cutaneous Radiation Injury Drug Key Players in Asia-Pacific
7.3 Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Type
7.4 Asia-Pacific Cutaneous Radiation Injury Drug Market Size by Application
8 International Players Profiles
8.1 Merck
8.1.1 Merck Company Details
8.1.2 Company Description and Business Overview
8.1.3 Cutaneous Radiation Injury Drug Introduction
8.1.4 Merck Revenue in Cutaneous Radiation Injury Drug Business (2014-2019))
8.1.5 Merck Recent Development
8.2 Novartis
8.2.1 Novartis Company Details
8.2.2 Company Description and Business Overview
8.2.3 Cutaneous Radiation Injury Drug Introduction
8.2.4 Novartis Revenue in Cutaneous Radiation Injury Drug Business (2014-2019)
8.2.5 Novartis Recent Development
8.3 Johnson & Johnson
8.3.1 Johnson & Johnson Company Details
8.3.2 Company Description and Business Overview
8.3.3 Cutaneous Radiation Injury Drug Introduction
8.3.4 Johnson & Johnson Revenue in Cutaneous Radiation Injury Drug Business (2014-2019)
8.3.5 Johnson & Johnson Recent Development
8.4 Pfizer
8.4.1 Pfizer Company Details
8.4.2 Company Description and Business Overview
8.4.3 Cutaneous Radiation Injury Drug Introduction
8.4.4 Pfizer Revenue in Cutaneous Radiation Injury Drug Business (2014-2019)
8.4.5 Pfizer Recent Development
8.5 Amgen
8.5.1 Amgen Company Details
8.5.2 Company Description and Business Overview
8.5.3 Cutaneous Radiation Injury Drug Introduction
8.5.4 Amgen Revenue in Cutaneous Radiation Injury Drug Business (2014-2019)
8.5.5 Amgen Recent Development
8.6 Roche
8.6.1 Roche Company Details
8.6.2 Company Description and Business Overview
8.6.3 Cutaneous Radiation Injury Drug Introduction
8.6.4 Roche Revenue in Cutaneous Radiation Injury Drug Business (2014-2019)
8.6.5 Roche Recent Development
8.7 Eli Lily
8.7.1 Eli Lily Company Details
8.7.2 Company Description and Business Overview
8.7.3 Cutaneous Radiation Injury Drug Introduction
8.7.4 Eli Lily Revenue in Cutaneous Radiation Injury Drug Business (2014-2019)
8.7.5 Eli Lily Recent Development
8.8 AstraZeneca
8.8.1 AstraZeneca Company Details
8.8.2 Company Description and Business Overview
8.8.3 Cutaneous Radiation Injury Drug Introduction
8.8.4 AstraZeneca Revenue in Cutaneous Radiation Injury Drug Business (2014-2019)
8.8.5 AstraZeneca Recent Development
8.9 Teva
8.9.1 Teva Company Details
8.9.2 Company Description and Business Overview
8.9.3 Cutaneous Radiation Injury Drug Introduction
8.9.4 Teva Revenue in Cutaneous Radiation Injury Drug Business (2014-2019)
8.9.5 Teva Recent Development
9 Market Forecast 2019-2025
9.1 Market Size Forecast by Product (2019-2025)
9.2 Market Size Forecast by Application (2019-2025)
9.3 Market Size Forecast by Regions
9.4 North America
9.5 Europe
9.6 Asia-Pacific
10 Analyst’s Viewpoints/Conclusions
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Disclaimer
11.3 Author Details
【掲載企業】
Merck、Novartis、Johnson & Johnson、Pfizer、Amgen、Roche、Eli Lily、AstraZeneca、Teva